Sevoflurane and desflurane in ischemia-reperfusion injury: Direct and remote organ protection from experimental to clinical evidence

Ischemia-reperfusion (I/R) injury is not confined to ischemic tissue.Oxidative stress, cytokine release, endothelial activation, and apoptosis may also damage organs that were not directly exposed to ischemia.Sevoflurane and desflurane reproduce several components of ischemic preconditioning through mitochondrial ATP-sensitive potassium channel activation, antioxidant signaling, suppression of inflammatory pathways, and reduced apoptosis.This narrative minireview draws on heterogeneous experimental studies and limited clinical evidence.It addresses two questions that are often merged: Whether these agents protect the ischemic organ itself and whether they protect an organ injured remotely after ischemia elsewhere.Six experimental studies were identified in remote injury models, three with each agent, and all six examined the lung.Remote renal and cardiac outcomes were each assessed in only one study, and no studies of remote hepatic or cerebral injury were identified.Only one of the six studies tested a pathway through inhibition.Direct organ-specific evidence is far more extensive for sevoflurane, with pathway testing through inhibition, knockdown, or knockout in the liver, kidney, brain, and lung.Fewer studies have examined desflurane.Several pathways were tested through intervention, but most findings derive from individual studies.Where the two agents have been compared under identical conditions, results diverge: Desflurane produced more reactive oxygen species and greater mitochondrial uncoupling in isolated myocytes and reduced infarct size more than sevoflurane in rabbit myocardium, while a proteomic comparison found no distinguishing pattern.Clinical findings mainly concern biomarkers and intraoperative events; isolated differences in acute kidney injury and prolonged intensive care unit stay have not established a consistent patient-centered benefit.The experimental evidence supports a remote pulmonary effect for both agents but does not yet support a general claim of remote multi-organ protection by either.

Authors

Institutions

Publication Details

Journal
World Journal of Experimental Medicine
Published
2026-11-18
DOI
https://doi.org/10.5493/wjem.127933
Primary Topic
Cardiac Ischemia and Reperfusion
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sevoflurane and desflurane in ischemia-reperfusion injury: Direct and remote organ protection from experimental to clinical evidence

Necmiye Şengel, Mustafa Arslan
World Journal of Experimental Medicine
Cardiac Ischemia and Reperfusion
article

Sevoflurane and desflurane in ischemia-reperfusion injury: Direct and remote organ protection from experimental to clinical evidence

Necmiye Şengel, Mustafa Arslan
article en

Abstract

Ischemia-reperfusion (I/R) injury is not confined to ischemic tissue.Oxidative stress, cytokine release, endothelial activation, and apoptosis may also damage organs that were not directly exposed to ischemia.Sevoflurane and desflurane reproduce several components of ischemic preconditioning through mitochondrial ATP-sensitive potassium channel activation, antioxidant signaling, suppression of inflammatory pathways, and reduced apoptosis.This narrative minireview draws on heterogeneous experimental studies and limited clinical evidence.It addresses two questions that are often merged: Whether these agents protect the ischemic organ itself and whether they protect an organ injured remotely after ischemia elsewhere.Six experimental studies were identified in remote injury models, three with each agent, and all six examined the lung.Remote renal and cardiac outcomes were each assessed in only one study, and no studies of remote hepatic or cerebral injury were identified.Only one of the six studies tested a pathway through inhibition.Direct organ-specific evidence is far more extensive for sevoflurane, with pathway testing through inhibition, knockdown, or knockout in the liver, kidney, brain, and lung.Fewer studies have examined desflurane.Several pathways were tested through intervention, but most findings derive from individual studies.Where the two agents have been compared under identical conditions, results diverge: Desflurane produced more reactive oxygen species and greater mitochondrial uncoupling in isolated myocytes and reduced infarct size more than sevoflurane in rabbit myocardium, while a proteomic comparison found no distinguishing pattern.Clinical findings mainly concern biomarkers and intraoperative events; isolated differences in acute kidney injury and prolonged intensive care unit stay have not established a consistent patient-centered benefit.The experimental evidence supports a remote pulmonary effect for both agents but does not yet support a general claim of remote multi-organ protection by either.

World Journal of Experimental Medicine
Gazi University (TR)
Good health and well-being
Cardiac Ischemia and Reperfusion
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon